KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Clorox (CLX) Shares Outstanding (Diluted Average) (2016 - 2026)

Clorox has reported Shares Outstanding (Diluted Average) over the past 18 years, most recently at $122.2 million for Q1 2026.

  • For Q1 2026, Shares Outstanding (Diluted Average) fell 1.79% year-over-year to $122.2 million; the TTM value through Mar 2026 reached $122.2 million, down 1.79%, while the annual FY2025 figure was $124.3 million, 0.41% changed from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2026 was $122.2 million at Clorox, roughly flat from $122.5 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $124.8 million in Q2 2024 and troughed at $122.2 million in Q1 2026.
  • A 5-year average of $124.0 million and a median of $124.2 million in 2023 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): decreased 2.67% in 2022 and later increased 0.6% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $124.0 million in 2022, then grew by 0.54% to $124.6 million in 2023, then increased by 0.04% to $124.7 million in 2024, then fell by 1.77% to $122.5 million in 2025, then dropped by 0.18% to $122.2 million in 2026.
  • Business Quant data shows Shares Outstanding (Diluted Average) for CLX at $122.2 million in Q1 2026, $122.5 million in Q4 2025, and $123.0 million in Q3 2025.